Starting operations in 1994, Syngene collaborated with a few large pharmaceutical, biotech and fine chemical companies offering discovery chemistry and biology services. Today, we cater to the requirements of a variety of industry sectors including pharmaceutical, biotechnology, agrochemicals, consumer goods, animal health, cosmetic and nutrition companies offering end-to-end discovery and development services. We are currently providing these services to over 300+ clients globally.
Long term relationships with customers are the spine of our business. Some of our strategic collaborations are with Bristol-Myers Squibb, Baxter and Amgen in Pharma and Herabalife in the nutrition industry, to name a few.
Syngene has successfully partnered not only with large multinational companies but also with small and virtual companies. We value all our partnerships, which are tailored to meet the needs of our clients at every step of their R&D product pipeline. The diversifications in our offerings are exemplified by the breadth of our clientele and the length of the relationships.
Over the past 20 years, Syngene has successfully partnered with the leading players in global pharmaceutical and biotech industry across a wide range of challenging programs, from discovery to supply of complex development compounds. We have successfully collaborated with 8 of the top 10 global pharmaceutical and biotech companies offering boutique as well as integrated services.
We also have clients from small pharmaceutical, virtual and startup biotech companies.
Syngene provides multi-disciplinary skills in integrated drug discovery and development, with capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing and formulation development for both small and large molecules.
The global animal health market has evolved substantially over the last 10 years in companion animals, dairy animals as well as livestock, etc. On the other hand Animal Health pharmaceuticals come with unique challenges related to cost, market size, diversity of animal species, etc.
Companies engaged in research, development, manufacturing and commercialization of veterinary medicines, vaccines and other animal healthcare products are therefore, looking for cost effective solutions to transform animal health and welfare.
To cater to the needs of this dynamic and innovative sector, Syngene is supporting various animal healthcare companies through a single study or a fully supported integrated program.
Agrochemical sector has seen considerable growth globally in recent years. We have collaborations with some of the leading global agrochemical companies, as well as companies based in India.
Syngene offers integrated discovery and development services with capabilities in discovery chemistry and biology, process development, formulation development, analytical R&D, phys-chem and 5-batch analysis as well as six pack acute tox packages in accordance with OECD/OPPTS (EPA) guidelines to support development programs.
An increasing requirement for affordable nutrition in the developing markets across the globe has necessitated nutrition companies to focus on research partners in order to cater to this growing demand. Syngene has developed state of the art capabilities to support the growing demand for nutrition research, offering services spanning across pre-clinical and clinical domains for general and medical nutrition research endeavours.
Our commitment to support Nutrition Science has helped us partner leading nutrition companies in the world like Herbalife Nutrition. Herbalife Nutrition tied up with Syngene to set-up Herbalife Nutrition Research and Development Center (HNRD).
Syngene is one of India’s leading Contract Research and Manufacturing Organization offering modular as well as integrated services to performance & specialty material industries.
Syngene also has the experience of collaborating with other industries including medical imaging & devices, diagnostics, petrochemical, electronics and cosmetics companies providing boutique services from our discovery and development capabilities platform.